Skip to content

Self-Control Study of Mongolian Mind-Body Interactive Psychotherapy in the Treatment of Essential Hypertension

Clinical and Mechanism Research Study of Mongolian Mind-Body Interactive Psychotherapy in Essential Hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000034918
Enrollment
Unknown
Registered
2020-07-24
Start date
2020-07-27
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Interventions

Hypertension:Mongolian Mind-body Interactive Psychotherapy
Normotension:Nil

Sponsors

Inetrnational Mongolian Medicine Hospital of Inner Mongolia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-65 years old. Male female ratio: 1:1; 2. Those with educational background above junior high school; 3. Patients with essential hypertension: mild or moderate level, according to the diagnostic criteria of essential hypertension; 4. Patients taking only one kind of antihypertensive drug or not taking drug; 5. Patients with rapid infection and negative chest X-ray examination; 6. Patients who voluntarily participate in the trial and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with pregnancy, lactation, or taking contraceptives; 2. Patients who are participating in other clinical trials or have participated in other clinical trials in the past month; 3. Patients who have drunk western medicine, Mongolian medicine, traditional Chinese medicine or other traditional medicine treatment other than antihypertensive drugs within 2 weeks and participated in psychosomatic interaction therapy of Mongolian medicine need to stop for more than 2 weeks before they can participate in this study; 4. Patients with mental illness status or history or history of alcohol and drug abuse affect the compliance with the study protocol; 5. Any other situation that affects the results of the study as judged by the doctor.

Design outcomes

Primary

MeasureTime frame
Blood pressure;

Secondary

MeasureTime frame
CRP;questionier;

Countries

China

Contacts

Public ContactNagongbilige Heriyed

Inner Mongolia International Mongolian Hospital

781871909@qq.com+86 18686039599

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026